[Form 4] Life360, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Life360, Inc. (LIF) reported that one of its directors exercised and sold shares under a pre-arranged trading plan. On 11/13/2025, the director exercised a stock option to acquire 7,930 shares of common stock at $11.18 per share and, on the same date, sold 7,930 shares of common stock at $76.93 per share. After these transactions, the director beneficially owned 105,456 shares of common stock, including 2,036 restricted stock units, and held 95,160 stock options. The filing notes that these trades were executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, and it corrects the vesting commencement date of the reported stock option to April 1, 2024.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prober Charles J.

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CA 94403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	11/13/2025		M(1)		7,930	A	$11.18	113,386(2)	D
Common stock	11/13/2025		S(1)		7,930	D	$76.93	105,456(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$11.18	11/13/2025		M(1)			7,930	(3)	04/12/2028	Common stock	7,930	$0	95,160	D

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

2. Includes 2,036 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

3. The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Remarks:

The vesting commencement date for the stock option reported herein was inadvertently reported as April 12, 2024 on the Reporting Person's initial Form 3 filed on June 27, 2022, and subsequent Forms 4 reporting transactions in the stock option, and has been corrected to April 1, 2024 as of this Form 4.

	/s/ Jay Sood, Attorney-in-Fact	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Life360 (LIF) report on this Form 4?

The filing reports that a director of Life360 exercised a stock option to acquire 7,930 shares of common stock at $11.18 per share on 11/13/2025 and sold 7,930 shares of common stock at $76.93 per share on the same date.

How many Life360 (LIF) shares does the reporting person own after the transaction?

Following the reported transactions, the director beneficially owned 105,456 shares of Life360 common stock, which includes 2,036 restricted stock units representing a right to receive shares upon vesting.

What stock options does the Life360 (LIF) director still hold?

After the transactions, the director held 95,160 stock options, including an option originally covering 7,930 shares of common stock that was exercised at an exercise price of $11.18 per share.

Was the Life360 (LIF) insider trade made under a Rule 10b5-1 plan?

Yes. The filing states that the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025, which provides for automatic trades based on predetermined criteria.

What correction to prior disclosures does this Life360 (LIF) Form 4 make?

The filing clarifies that the vesting commencement date for the reported stock option is April 1, 2024. Earlier filings had inadvertently reported this date as April 12, 2024, and this Form 4 corrects that detail.

How do the restricted stock units (RSUs) for the Life360 (LIF) director work?

The filing notes that the director holds 2,036 restricted stock units, each representing a contingent right to receive one share of Life360 common stock upon vesting, subject to the applicable vesting conditions.